CL2009001747A1 - Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales. - Google Patents

Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.

Info

Publication number
CL2009001747A1
CL2009001747A1 CL2009001747A CL2009001747A CL2009001747A1 CL 2009001747 A1 CL2009001747 A1 CL 2009001747A1 CL 2009001747 A CL2009001747 A CL 2009001747A CL 2009001747 A CL2009001747 A CL 2009001747A CL 2009001747 A1 CL2009001747 A1 CL 2009001747A1
Authority
CL
Chile
Prior art keywords
eugenol
xylitol
excipients
preparation
pharmaceutical composition
Prior art date
Application number
CL2009001747A
Other languages
English (en)
Inventor
González Tomás Bernardo Galván
Original Assignee
Galvan Gonzalez Tomas Bernardo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvan Gonzalez Tomas Bernardo filed Critical Galvan Gonzalez Tomas Bernardo
Priority to CL2009001747A priority Critical patent/CL2009001747A1/es
Priority to PT108094145T priority patent/PT2510916T/pt
Priority to BR112012003842-7A priority patent/BR112012003842B1/pt
Priority to RU2012110038/15A priority patent/RU2558061C2/ru
Priority to DK10809414.5T priority patent/DK2510916T3/en
Priority to PCT/CL2010/000030 priority patent/WO2011020206A1/es
Priority to US13/391,334 priority patent/US8865136B2/en
Priority to CN2010800434354A priority patent/CN102639100A/zh
Priority to EP10809414.5A priority patent/EP2510916B1/en
Priority to ES10809414.5T priority patent/ES2632363T3/es
Publication of CL2009001747A1 publication Critical patent/CL2009001747A1/es
Priority to IN2053DEN2012 priority patent/IN2012DN02053A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICIÓN FARMACÉUTICA ANTISÉPTICA, QUE COMPRENDE:<br /> 0,05 Y 0,3% P/P DE PERÓXIDO DE HIDRÓGENO O SU EQUIVALENCIA EN PERÓXIDO DE CARBAMIDA;<br /> 0,001 Y 0,03% P/P DE EUGENOL;<br /> 0,001 Y 0,01% P/P DE ALCANFOR;<br /> 0,001 Y 0,5% P/P DE UNA SAL DE ZINC U OTROS METALES PESADOS COMO PLATA, MERCURIO, COBRE O ESTAÑO<br /> O MEZCLA DE LOS MISMOS;<br /> 1 A 1,2% P/P DE FLUORURO DE SODIO;<br /> 2% A 7% P/P DE XILITOL; Y<br /> EXCIPIENTES EN CANTIDAD SUFICIENTE PARA ENTERAR 100% DE LA COMPOSICIÓN TOTAL; MÉTODO DE PREPARACIÓN DE LA<br /> MISMA; Y SU USO PARA PREVENIR Y/O TRATAR ENFERMEDADES ORALES.<br />  
CL2009001747A 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales. CL2009001747A1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CL2009001747A CL2009001747A1 (es) 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.
PCT/CL2010/000030 WO2011020206A1 (es) 2009-08-20 2010-08-19 Composición farmacéutica antiséptica útil para la higiene bucal y el tratamiento de las enfermedades orales de origen microbiano
BR112012003842-7A BR112012003842B1 (pt) 2009-08-20 2010-08-19 Composição antisséptica, método de formulação e uso da mesma
RU2012110038/15A RU2558061C2 (ru) 2009-08-20 2010-08-19 Антисептическая фармацевтическая композиция для гигиены полости рта и лечения заболеваний полости рта микробного происхождения
DK10809414.5T DK2510916T3 (en) 2009-08-20 2010-08-19 ANTISEPTIC PHARMACEUTICAL COMPOSITION FOR ORAL HYGIENE AND THE TREATMENT OF ORAL DISEASES OF MICROBIAL ORIGIN
PT108094145T PT2510916T (pt) 2009-08-20 2010-08-19 Composição farmacêutica antisséptica para a higiene oral e o tratamento de doenças bucais de origem microbiana
US13/391,334 US8865136B2 (en) 2009-08-20 2010-08-19 Antiseptic pharmaceutical composition for oral hygiene and the treatment of oral diseases of microbial origin
CN2010800434354A CN102639100A (zh) 2009-08-20 2010-08-19 用于口腔卫生和治疗微生物起源的口腔疾病的抗菌药物组合物
EP10809414.5A EP2510916B1 (en) 2009-08-20 2010-08-19 Antiseptic pharmaceutical composition for oral hygiene and the treatment of oral diseases of microbial origin
ES10809414.5T ES2632363T3 (es) 2009-08-20 2010-08-19 Composición farmacéutica antiséptica para la higiene bucal y el tratamiento de enfermedades bucales de origen microbiano
IN2053DEN2012 IN2012DN02053A (es) 2009-08-20 2012-03-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2009001747A CL2009001747A1 (es) 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.

Publications (1)

Publication Number Publication Date
CL2009001747A1 true CL2009001747A1 (es) 2010-09-10

Family

ID=43606512

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001747A CL2009001747A1 (es) 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.

Country Status (11)

Country Link
US (1) US8865136B2 (es)
EP (1) EP2510916B1 (es)
CN (1) CN102639100A (es)
BR (1) BR112012003842B1 (es)
CL (1) CL2009001747A1 (es)
DK (1) DK2510916T3 (es)
ES (1) ES2632363T3 (es)
IN (1) IN2012DN02053A (es)
PT (1) PT2510916T (es)
RU (1) RU2558061C2 (es)
WO (1) WO2011020206A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013055478A1 (en) * 2011-10-10 2013-04-18 Ultradent Products, Inc Anti-plaque dental compositions
ES2885449T3 (es) * 2013-02-07 2021-12-13 Ingalfarma Spa Composición antiséptica oral para el tratamiento de mucositis oral
CH707698A1 (de) * 2013-03-12 2014-09-15 Bonyf Ag Pharmazeutisches Mittel zur Behandlung von Schleimhautentzündungen.
WO2015041523A1 (en) 2013-09-18 2015-03-26 Glymur B.V. Oral hygiene compositions
AU2015335908B2 (en) * 2014-10-23 2018-04-05 Colgate-Palmolive Company Oral care compositions comprising zinc compounds and peroxide compounds
RU2600443C1 (ru) * 2015-07-17 2016-10-20 Леонид Борисович Потёмкин Лечебно-профилактическая зубная паста
CN105327337A (zh) * 2015-10-30 2016-02-17 中国人民解放军96617部队 抗辐射防龋消炎口腔制剂
CN107441020B (zh) * 2017-08-14 2020-09-29 武汉美一棠口腔有限公司 种植牙术后保养液及种植牙术后保养方法
JP2018048155A (ja) * 2017-10-05 2018-03-29 ゴンザレス トマス ベルナルド ガルヴァン 口腔粘膜炎を治療するための口腔殺菌性組成物
US20200289379A1 (en) * 2017-10-26 2020-09-17 Bernardino Reynoso Oral care compositions and methods of use
CN108126128A (zh) * 2018-02-02 2018-06-08 上海哈美实业发展有限公司 一种口腔抗菌凝胶剂及其制备方法
US12053485B2 (en) 2018-06-25 2024-08-06 Triumph Pharmaceuticals Inc. Methods of inhibiting microbial infections using zinc-containing compositions
EP3986363B1 (en) 2019-06-24 2025-12-03 WiQo S.p.A. Formulations for odontological and dermatological use containing trichloroacetate salts and hydroxyacids
CN112533623A (zh) * 2019-07-04 2021-03-19 株式会社索辛 动物用的口腔用组合物及使用了它的动物用的牙周病预防剂、传染病预防剂及口臭预防剂
CN114787363A (zh) 2019-10-01 2022-07-22 恩派瑞安神经科学公司 对真菌进行遗传工程化以调节色胺表达
BR102019021197A2 (pt) * 2019-10-09 2021-04-20 Luiz Jabbur Junior agente de gargarejo compreendendo um conjunto de substâncias acopladas, método de uso e controle do caseum
ES3062133T3 (en) 2020-02-18 2026-04-08 Sunstar Americas Inc Oral care composition
US11638722B2 (en) * 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
EP4216918A4 (en) * 2020-09-24 2024-11-13 Medline Industries, LP ORAL RINSE COMPOSITION, ORAL CLEANING KIT, METHOD FOR CLEANING ORAL CAVITY AND METHOD FOR MANUFACTURING ORAL RINSE COMPOSITION
US20230355492A1 (en) * 2020-11-09 2023-11-09 Colgate-Palmolive Company Oral Care Compositions and Preservative Systems
US20250195566A1 (en) * 2021-07-02 2025-06-19 Ingalfarma Spa Oral pharmaceutical composition for preventing and/or treating diseases of the soft and hard tissues surrounding the tooth in the oral cavity
WO2023130078A2 (en) 2021-12-31 2023-07-06 Empyrean Neuroscience, Inc. Genetically modified mycelium for producing psychotropic alkaloids

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387647A1 (fr) * 1977-04-20 1978-11-17 Spad Lab Pate de traitement endodontique pour l'obturation canalaire de dents
US4226851A (en) * 1979-07-11 1980-10-07 Sompayrac Hewitt A Stable dental composition containing hydrogen peroxide
US4436721A (en) * 1983-06-08 1984-03-13 Colgate-Palmolive Company Oral composition having mole ratio of tetra (methylene phosphonate) to alkali metal fluoride of at least 1.4:1
GB8411841D0 (en) 1984-05-09 1984-06-13 Unilever Plc Oral compositions
US5174990A (en) * 1990-02-07 1992-12-29 7-L Corporation Mouthrinse and method of preparation
US5104644A (en) 1990-02-07 1992-04-14 7-L Corporation Mouthrinse composition
AU1533697A (en) * 1996-01-24 1997-08-20 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
WO2000000166A2 (en) * 1998-06-29 2000-01-06 Warner-Lambert Company Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis
US6723305B2 (en) * 2002-03-04 2004-04-20 Colgate Palmolive Company Anti-microbial breath freshening mouthrinse
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
US20060045854A1 (en) * 2004-08-27 2006-03-02 Lynette Zaidel Oral care composition with cross-linked polymer peroxide
US20060140882A1 (en) * 2004-12-29 2006-06-29 Tambs Gary E Two phase whitening oral care composition
BRPI0502145A (pt) * 2005-06-03 2007-01-23 Mauricio Duarte Da Conceicao enxaguatório para prevenção e tratamento da halitose
US20090191510A1 (en) * 2005-06-22 2009-07-30 Cao Group, Inc. Periodontal treatment employing applied ultrasonic energy
US8337819B2 (en) * 2005-06-28 2012-12-25 Tomas Bernardo Galvan Pharmaceutical composition for the oral hygiene, the treatment of the periodontal illnesses and the halitosis
WO2007042472A1 (en) * 2005-10-14 2007-04-19 Symrise Gmbh & Co. Kg Synergistic mixtures of bisabolol and ginger extract
RU2420088C2 (ru) * 2006-02-24 2011-06-10 КЭДБЕРИ АДАМС ЮЭсЭй ЛЛС Композиция для жевательной резинки с жидким наполнителем
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral

Also Published As

Publication number Publication date
DK2510916T3 (en) 2017-07-24
EP2510916A1 (en) 2012-10-17
IN2012DN02053A (es) 2015-08-21
RU2558061C2 (ru) 2015-07-27
BR112012003842B1 (pt) 2023-11-28
CN102639100A (zh) 2012-08-15
US8865136B2 (en) 2014-10-21
PT2510916T (pt) 2017-07-13
RU2012110038A (ru) 2013-09-27
EP2510916A4 (en) 2016-01-20
ES2632363T3 (es) 2017-09-12
WO2011020206A1 (es) 2011-02-24
US20120148506A1 (en) 2012-06-14
EP2510916B1 (en) 2017-04-05
BR112012003842A2 (pt) 2016-03-22

Similar Documents

Publication Publication Date Title
CL2015001694A1 (es) Composicion que comprende un complejo de haluro de zinc tetrabasico-aminoacido o trialquil glicina y cisteina en forma libre o de sal aceptable oralmente o cosmetico; y su uso para eliminar bacterias, reducir la transpiracion y/o el olor corporal, tratar o reducir el acne, limpiar los dientes e inhibir las caries, entre otros.
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
CL2010000935A1 (es) Compuestos derivados de niacina unida a un acido graso; composicion farmaceutica que los comprende; y su uso para tratar una enfermedad metabolica tal como hipertrigliceridemia, hipercolesterolemia, diabetes tipo 2 y retinopatia diabetica.
PE20130063A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
AR093792A1 (es) Composiciones que contienen zinc estables al fluoruro
BR112014009031A2 (pt) formulações de etanercept estabilizadas com íons de metais
AR052057A1 (es) Composiciones orales que contienen extractos de rosmarinus y metodos ralacionados
PH12013500721A1 (en) Oral care product and methods of use and manufacture thereof
UY32109A (es) Métodos para utilizar composiciones de liberación sostenida de aminopiridina
CR11418A (es) Trans-clomifeno para el sindrome metabolico
UA107103C2 (uk) Нікотиновмісні м&#39;які желатинові пастилки
MX2012001168A (es) Composiciones para el cuidado bucal que comprenden estaño, potasio y monofluorofosfato.
TW200744617A (en) Agent increasing the production of thioredoxin
AR089269A1 (es) Composiciones para el cuidado oral
CL2012002815A1 (es) Composicion para el cuidado bucal que comprende uno o mas compuesto de curcumina y una fuente de iones de zinc; correspondiente a 0.02 a 3% en peso de citrato de zinc; y uso de una fuente de iones de zinc para suprimir la degradacion y/o decoloracion del compuesto de curcumina en una composicion ara el cuidado bucal.
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
AR085042A1 (es) Composiciones de cuidado oral con extracto de magnolia
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
AR070593A1 (es) Composiciones efervescentes
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
AR083329A1 (es) Composiciones para el cuidado oral